Cleveland Clinic, officials look to open 'Medical Mart'; NuVasive completes Impluse Monitoring buy;

> The Cleveland Clinic's Dr. Toby Cosgrove and area officials are hoping to attract a year-round exhibition center for medical equipment and devices to downtown Cleveland. Medical Mart would be modeled after and run by the managers of Chicago's successful Merchandise Mart. Item

> NuVasive ($NUVA) has completed the previously announced acquisition of Impulse Monitoring, a leading intra-operative monitoring provider in the U.S. NuVasive release

> Philips Respironics, a unit of Royal Philips Electronics ($PHG), has released what it calls its most advanced continuous positive airway pressure device to date: the REMstar Pro with AutoIQ. Philips release

> British Columbia's BioCurex has submitted scientific information and a request for a meeting regarding an IDE to the FDA for the use of RECAF in conjunction with PSA to decrease the number of unnecessary prostate biopsies. BioCurex release

> Spinal USA has created more than 25 new jobs in Jackson, MS, and has nearly doubled its overall workforce since June 2010. The company anticipates further U.S. job creation in the coming year. Spinal USA release

> The Detroit Medical Center Cardiovascular Institute has become the first Michigan cardiac care facility to open a patient's blocked artery with a technology that operates like an electrically powered corkscrew drill to remove the plaque buildup that causes peripheral artery disease. Detroit Medical Center release

And Finally... The Cleveland Clinic has announced its "Top 10 Medical Innovations for 2012," including wearable bionic devices, a concussion management system for athletes and an implant for brain aneurysms. Cleveland Clinic list

Suggested Articles

J&J launched a virtual clinical study to gauge whether Apple’s iPhone and ECG-enabled smartwatch can help reduce the risk of stroke and catch AFib.

The Salt Lake City-based developer said its Logix Smart test is now available to be exported from Utah to countries requiring the CE Mark.

Dexcom received a new European approval for its wearable continuous glucose monitor in pregnant women across Type 1, Type 2 and gestational diabetes.